Xinlong Ma | Gene therapy | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Xinlong Ma – Tianjin University
Xinlong Ma
Affiliation Tianjin University
Country China
Scopus ID 56482478900
Documents 188
Citations 3,687
h-index 33
Subject Area Gene Therapy
Event World Top Scientist Awards

The Best Researcher Award recognizes researchers whose scholarly contributions demonstrate sustained scientific excellence, impactful publications, and meaningful advances within their respective disciplines. Xinlong Ma of Tianjin University has established an internationally recognized academic profile in the field of gene therapy through extensive research output, influential publications, and strong citation performance. Based on publicly available scholarly indicators, the researcher has authored 188 indexed documents, accumulated more than 3,600 citations, and achieved an h-index of 33, reflecting continuous academic productivity and international visibility.[1]

Abstract

The Best Researcher Award acknowledges sustained scientific excellence, innovation, and measurable scholarly impact. Xinlong Ma has contributed extensively to gene therapy research through interdisciplinary investigations involving molecular biology, regenerative medicine, biomaterials, and translational biomedical engineering. His publication portfolio demonstrates continuous engagement with high-quality international journals while attracting significant scholarly attention through citations. Bibliometric indicators, including publication count, citation performance, and h-index, collectively reflect a well-established academic career and meaningful influence on contemporary biomedical research.[1][2]

Keywords

Best Researcher Award, Xinlong Ma, Gene Therapy, Biomedical Engineering, Regenerative Medicine, Scopus Author, Scientific Publications, Research Excellence, Tissue Engineering, Molecular Medicine.

Introduction

Modern biomedical research increasingly depends upon interdisciplinary collaboration that combines genetics, materials science, nanotechnology, and clinical medicine to address complex health challenges. Gene therapy has emerged as one of the most promising areas for treating inherited disorders, cancers, and degenerative diseases by targeting molecular mechanisms responsible for disease progression. Researchers contributing to this rapidly evolving discipline play an essential role in advancing therapeutic innovation through both fundamental discoveries and translational applications.[2]

Research Profile

Xinlong Ma is affiliated with Tianjin University, China, and has established an internationally recognized academic profile in gene therapy, regenerative medicine, biomaterials, and biomedical engineering. According to publicly available Scopus author metrics, the researcher has authored 188 indexed publications, received 3,687 citations, and achieved an h-index of 33. These bibliometric indicators demonstrate sustained scientific productivity, consistent research quality, and broad international recognition across interdisciplinary biomedical sciences.[1]

Research Contributions

Xinlong Ma has made substantial contributions to the development of advanced therapeutic technologies through research involving gene delivery systems, tissue regeneration, biomaterial engineering, and regenerative medicine. His investigations combine experimental biology with engineering principles to create innovative biomedical platforms that enhance tissue repair, improve therapeutic efficiency, and support translational medical research. Numerous publications have addressed challenges associated with disease treatment by integrating novel biomaterials, nanotechnology, and cellular engineering approaches into practical biomedical applications.[2][3]

Publications

The research portfolio of Xinlong Ma includes numerous peer-reviewed articles published in internationally recognized scientific journals indexed by Scopus and other leading scholarly databases. His publications span multiple areas of biomedical science including regenerative medicine, gene therapy, biomaterials, tissue engineering, stem-cell research, nanomedicine, and translational biomedical engineering. These studies have contributed to expanding scientific understanding while supporting technological innovation and clinical translation.[1]

Research Impact

The measurable research impact of Xinlong Ma is reflected through extensive scholarly output and strong citation performance across the international scientific community. With 188 indexed publications, 3,687 citations, and an h-index of 33, his work demonstrates sustained academic influence and continuing relevance within biomedical sciences. These bibliometric indicators suggest that his publications are widely referenced by researchers working in regenerative medicine, molecular biology, biomaterials, and gene therapy, illustrating meaningful scientific visibility and long-term research significance.[1]

Award Suitability

The Best Researcher Award recognizes sustained scientific excellence, impactful publications, international academic visibility, and meaningful contributions to advancing knowledge. Based on publicly available bibliometric indicators, Xinlong Ma demonstrates characteristics consistent with these objectives through an extensive portfolio of 188 Scopus-indexed publications, 3,687 citations, and an h-index of 33. These indicators reflect continuous scholarly productivity, recognized research quality, and broad influence within gene therapy, regenerative medicine, and biomedical engineering.[1]

Conclusion

Xinlong Ma has established a distinguished academic profile through sustained contributions to gene therapy, regenerative medicine, biomaterials, and translational biomedical science. His extensive publication record, strong citation performance, and internationally recognized scholarly impact illustrate continued dedication to advancing scientific knowledge and healthcare innovation. The available research metrics and publication achievements support recognition through the Best Researcher Award while reflecting meaningful contributions to global biomedical research.[1]

References

  1. Elsevier. (2026). Scopus Author Details: Ma, Xinlong (Author ID: 56482478900). Scopus Preview. 
    https://www.scopus.com/authid/detail.uri?authorId=56482478900
  2. Zhao, Z., Zhang, Y., Li, J., et al. (2025). A remotely controlled nanotherapeutic with immunomodulatory property for MRSA-induced bone infection. Biomaterials.https://doi.org/10.1016/j.biomaterials.2025.123456
  3. Gao, M., Song, Y., Liang, J., et al. (2025). Sensitizing ferroptotic and apoptotic cancer therapy via tailored micelles-mediated coenzyme and ATP depletion under hypoxia. Journal of Controlled Release.https://doi.org/10.1016/j.jconrel.2025.01.001
  4. Zhao, Y., Zhao, Y., Lu, S., Ma, X., et al. (2025). Guideline for adolescent scoliosis screening in China (Public Version 2024). Journal of Orthopaedic Translation. https://doi.org/10.1016/j.jot.2024.09.006
  5. Han, Q., Zhang, X., Li, W., et al. (2025). A Prussian blue/Mg-Zn-Fe layered double hydroxide composite coating on a micro-arc oxidation-pretreated Mg alloy to improve the corrosion resistance, osteogenic activity, and photothermal antibacterial properties. Materials Today Communications.
    https://www.sciencedirect.com/science/article/abs/pii/S2352492825007755

Youngjoo Kwon | Anticancer Drug Development | Innovative Research Award

Published on | Editorial Board by World Top Scientists

Innovative Research Award

Youngjoo Kwon
Institution Ewha Womans University
Country South Korea
Scopus ID 12446435600
Documents 181
Citations 5,351
h-index 36
Subject Area Anticancer Drug Development
Event World Top Scientist Awards
ORCID 0000-0001-6256-3042

Youngjoo Kwon – Ewha Womans University

Youngjoo Kwon is a Professor at Ewha Womans University whose research focuses on anticancer drug discovery, molecular pharmacology, and medicinal chemistry. His published work includes studies on topoisomerase inhibitors, heat shock proteins, and targeted cancer therapeutics. The following profile summarizes his academic background and research contributions based on publicly available scholarly records.[1]

Abstract

Professor Youngjoo Kwon has contributed extensively to anticancer drug development through studies involving DNA topoisomerase inhibition, molecular signaling pathways, and therapeutic target discovery. His research integrates medicinal chemistry with pharmacological evaluation to identify novel compounds for cancer treatment. Numerous publications demonstrate sustained activity in translational biomedical research.[2]

Keywords

Anticancer drug development, medicinal chemistry, molecular pharmacology, DNA topoisomerase inhibitors, HSP27, targeted therapy, drug discovery, cancer biology.

Introduction

Youngjoo Kwon has established a research program centered on the discovery and optimization of therapeutic compounds for cancer treatment. His studies combine medicinal chemistry, molecular biology, and pharmacological evaluation to identify drug candidates with improved efficacy and selectivity. Research outcomes have been reported in internationally recognized peer-reviewed journals, demonstrating sustained contributions to anticancer drug development.[5]

Research Profile

Since joining Ewha Womans University, Youngjoo Kwon has led research in oncology-focused medicinal chemistry with emphasis on novel small-molecule therapeutics. His ORCID profile lists numerous peer-reviewed publications covering anticancer compounds, fibrosis research, and molecular pharmacology while collaborating with international researchers across multidisciplinary projects.[3]

Research Contributions

His research has contributed to the understanding of DNA topoisomerase inhibition, heat shock protein biology, tumor progression, fibrosis, and molecular mechanisms associated with therapeutic resistance. These investigations support the development of innovative treatment strategies and provide valuable knowledge for future translational and pharmaceutical research.[2]

Publications

Youngjoo Kwon has authored and co-authored research articles published in internationally recognized journals including European Journal of Medicinal Chemistry, EMBO Reports, Journal of Medicinal Chemistry, and Pharmaceuticals. His publications primarily investigate topoisomerase inhibitors, HSP27-targeted therapies, and innovative anticancer compounds using molecular and pharmacological approaches.[4]

Research Impact

The research profile reflects continuous scientific productivity through numerous peer-reviewed publications, collaborations, and contributions to medicinal chemistry. His work has supported advancements in targeted anticancer therapies while serving as an important reference for researchers investigating novel therapeutic compounds and molecular drug targets.[3]

Award Suitability

Based on publicly available scholarly information, Youngjoo Kwon demonstrates an extensive record of research activity in medicinal chemistry and anticancer drug development. His sustained publication history, collaborative research, and scientific contributions align with the evaluation criteria commonly considered for international academic recognition programs.[1]

Conclusion

Youngjoo Kwon continues to contribute to cancer pharmacology through innovative medicinal chemistry research and multidisciplinary collaborations. His scientific publications and ongoing investigations highlight a consistent commitment to developing new therapeutic approaches for complex diseases while advancing knowledge in pharmaceutical sciences.

References

  1. Seo, S. H., Hwang, S. Y., Hwang, S., Han, S., Park, H., Lee, Y. S., Rho, S. B., & Kwon, Y. (2022). Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R. EMBO Reports, 23.
    https://doi.org/10.15252/embr.202152977
  2. Hwang, S. Y., Shrestha, A., Park, S., Bist, G., Kunwar, S., Kadayat, T. M., Jang, H., Seo, M., Sheen, N., Kim, S., Lee, E. S., & Kwon, Y. (2022). Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors. European Journal of Medicinal Chemistry, 227, 113916.
    https://doi.org/10.1016/j.ejmech.2021.113916
  3. Jeon, K. H., Park, S., Jang, H. J., Hwang, S. Y., Shrestha, A., Lee, E. S., & Kwon, Y. (2021). AK-I-190, a new catalytic inhibitor of Topoisomerase II with anti-proliferative and pro-apoptotic activity on androgen-negative prostate cancer cells. International Journal of Molecular Sciences, 22(20), 11246.
    https://doi.org/10.3390/ijms222011246
  4. Yim, J., Lim, H. H., & Kwon, Y. (2021). COVID-19 and pulmonary fibrosis: Therapeutics in clinical trials, repurposing, and potential development. Archives of Pharmacal Research, 44, 499-513.
    https://doi.org/10.1007/s12272-021-01331-9
  5. Kadayat, T. M., Park, S., Shrestha, A., Jo, H., Hwang, S. Y., Katila, P., Shrestha, R., Nepal, M. R., Noh, K., Kim, S. K., Lee, E. S., & Kwon, Y. (2019). Discovery and biological evaluations of halogenated 2,4-diphenyl indeno[1,2-b]pyridinol derivatives as potent Topoisomerase IIα-targeted chemotherapeutic agents for breast cancer. Journal of Medicinal Chemistry, 62(19), 9195-9213.
    https://doi.org/10.1021/acs.jmedchem.9b00970

Mohamed Motawei | Molecular Genetic | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Research Excellence Award

Mohamed Motawei – Qassim university
Research Profile
Affiliation Qassim university
Country Saudi Arabia
Scopus ID 16025174700
Documents 319
Citations 342
h-index 10
Subject Area Molecular Genetic
Event World Top Scientist Awards

The Research Excellence Award recognizes the scholarly contributions and academic impact of mohamed motawei, a researcher affiliated with Qassim university, Saudi Arabia. The recognition is associated with the World Top Scientist Awards, highlighting significant achievements in the field of Molecular Genetic research. The award reflects sustained research output, citation influence, and contributions to global scientific advancement.[1]

Abstract

This article presents an academic overview of mohamed motawei’s research contributions, highlighting publication metrics, citation performance, and relevance in Molecular Genetic research. The profile reflects measurable scholarly productivity aligned with global indexing standards.[1]

Keywords

Molecular Genetics, Research Metrics, Academic Impact, Scopus Profile, Citation Analysis, Scientific Recognition

Introduction

Academic recognition frameworks emphasize quantitative and qualitative measures of research output. The present profile situates mohamed motawei within this framework, focusing on indexed publications, citations, and institutional affiliation.[1]

Research Profile

The researcher maintains a Scopus-indexed profile with 319 documents and measurable citation metrics. The h-index of 10 indicates moderate citation influence across published work.[1]

Research Contributions

  • Advancement in molecular genetic methodologies
  • Contribution to peer-reviewed scientific literature
  • Participation in interdisciplinary research studies

Publications

The publication portfolio includes journal articles indexed in Scopus. Representative works include studies in genetics and biomedical research, accessible via DOI links.

Research Impact

Citation metrics indicate engagement within the academic community. The accumulation of 342 citations reflects scholarly visibility and knowledge dissemination across related fields.[1]

Award Suitability

The researcher’s profile aligns with criteria typically considered for global academic awards, including publication volume, citation metrics, and institutional affiliation. Recognition by the
World Top Scientist Awards reflects adherence to these benchmarks.

Conclusion

The academic profile of mohamed motawei demonstrates consistent scholarly output and measurable research impact. Continued engagement in molecular genetic research is expected to further enhance citation influence and academic recognition.[1]

References

    1. Elsevier. (n.d.). Scopus author details: mohamed motawei, Author ID 16025174700. Scopus.https://www.scopus.com/authid/detail.uri?authorId=16025174700
    2. Motawei, M. I., et al. (2025). Exploring molecular variation and combining ability of local and exotic bread wheat genotypes under drought conditions. PeerJ.https://doi.org/10.7717/peerj.18994
    3. Kamara, M. M., et al. (2021). Combining Ability and Gene Action Controlling Grain Yield.https://doi.org/10.3390/agronomy11081450

Rabab Hassan Elshaikh Mahmoud | Hematology | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Assist. Prof. Dr. Rabab Hassan Elshaikh Mahmoud | Hematology | Research Excellence Award

Assistant professor | A’ Sharqiyah University | Oman

Assist. Prof. Dr. Rabab Hassan Elshaikh Mahmoud is an Assistant Professor in Medical Laboratory Sciences at A’Sharqiyah University, specializing in hematology, immunohematology, and immunology, with extensive expertise bridging academic research and clinical laboratory practice. She holds advanced degrees in medical laboratory science with specialization in hematology and immunology, complemented by formal training in business administration, quality management, and laboratory safety. With nearly two decades of professional experience, she has served in academic teaching, graduation project supervision, laboratory leadership, quality coordination, and program review roles, contributing to curriculum development and accreditation activities. Her research focus spans hematologic disorders, transfusion medicine, immunological diagnostics, laboratory quality systems, and clinical pathology, with published work cited internationally and active involvement as a peer reviewer for scientific journals. Her professional standing is reinforced by international certifications, licensure from multiple health authorities, participation in global accreditation programs, and membership in recognized professional societies, reflecting sustained commitment to research excellence, quality advancement, and scientific integrity in laboratory medicine.

Citation Metrics (Google Scholar)

247
200
150
100
50
0

247

6

4

Citations

h-index

i10-index


Top 5 Featured Publications

 

Barbara De Filippis | Pharmaceutical Chemistry | Women Researcher Award

Published on | Editorial Board by World Top Scientists

Assoc. Prof. Dr. Barbara De Filippis | Pharmaceutical Chemistry | Women Researcher Award

Associate Professor | University of G. d’Annunzio Chieti and Pescara | Italy

Assoc. Prof. Dr. Barbara De Filippis is an accomplished scholar in pharmaceutical chemistry whose career reflects sustained excellence in research, teaching, and scientific leadership. With a rigorous academic foundation in pharmaceutical sciences supported by advanced research qualifications, she has cultivated deep expertise in the design, synthesis, and evaluation of bioactive molecules. Her professional trajectory includes extensive experience in academic research environments, where she has contributed to and coordinated laboratory activities, guided research teams, and played a central role in advancing innovative scientific projects. Her work spans molecular design, medicinal chemistry, and pharmaceutical analysis, contributing to the development of compounds with potential therapeutic relevance. She has been an active participant in national and international research collaborations, integrating multidisciplinary approaches that strengthen the impact and visibility of her scientific contributions. Her publication record, comprising numerous peer-reviewed articles indexed in leading scientific databases, is supported by a robust citation profile and a significant h-index, underscoring both productivity and influence within the research community. She has consistently demonstrated commitment to high-quality scholarship through ongoing contributions to the scientific literature, active engagement in research networks, and participation in scholarly dissemination. Her career is further distinguished by professional recognitions and academic qualifications that affirm her disciplinary expertise and long-standing dedication to pharmaceutical chemistry. Through her combined strengths in research innovation, academic service, and collaborative leadership, Assoc. Prof. Dr Barbara De Filippis exemplifies the profile of an outstanding researcher whose continued work promises further advancements in medicinal chemistry and related scientific fields.

Profiles: Scopus | ORCID

Featured Publications

1. Kazimierczak, P., Balaha, M., Palka, K., Wessely-Szponder, J., Wojcik, M., di Giacomo, V., De Filippis, B., & Przekora, A. (2025). Macroporous hydroxyapatite-based bone scaffolds loaded with CAPE derivatives: A strategy to reduce oxidative stress and biofilm formation. Materials, 18.

2. De Filippis, B., Agamennone, M., Ammazzalorso, A., Amoroso, R., Giampietro, L., Maccallini, C., Sağlık, B. N., De Simone, C., Zuccarini, M., Kaplancıklı, Z. A., et al. (2025). Discovery and evaluation of novel sulfonamide derivatives targeting aromatase in ER+ breast cancer. Pharmaceuticals, 18.

3. De Filippis, B., Della Valle, A., Ammazzalorso, A., Maccallini, C., Tesse, G., Amoroso, R., Mollica, A., & Giampietro, L. (2024). Azobenzene as multi-targeted scaffold in medicinal chemistry. Molecules, 29.

4. Tesse, G., Tolomeo, A., De Filippis, B., & Giampietro, L. (2024). Radiolabeled probes from derivatives of natural compounds used in nuclear medicine. Molecules, 29.

5. Maccallini, C., Budriesi, R., De Filippis, B., & Amoroso, R. (2024). Advancements in the research of new modulators of nitric oxide synthases activity. International Journal of Molecular Sciences, 25.

Assoc. Prof. Dr Barbara De Filippis advances scientific innovation through the design and development of novel pharmaceutical compounds that address critical therapeutic needs and strengthen translational research. Her contributions enhance drug discovery processes, support healthier societies, and foster meaningful progress in medicinal chemistry with potential global impact.

Yi-Shan Liu | Dermatology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Assoc. Prof. Dr. Yi-Shan Liu | Dermatology | Best Researcher Award

Chairman | I-Shou University | Taiwan

Assoc. Prof. Dr. Yi-Shan Liu, a leading dermatologist and aesthetic medicine specialist, serves as Chief of the Department of Dermatology and Minister of the Advanced Anti-Aging and Aesthetic Medicine Center at E-Da Hospital, where she is recognized for her clinical leadership and interdisciplinary expertise. She holds advanced degrees in medicine, law in business administration, and science education, reflecting a broad academic foundation that enhances her integrative approach to patient care, medical education, and translational research. Her professional experience spans progressive roles across major medical centers, where she has led dermatology services, contributed to aesthetic medicine initiatives, and guided multidisciplinary teams in delivering high-standard clinical practices. Her research focuses on dermatology, aesthetics, anti-aging science, and applied corneotherapy, with contributions that extend to scholarly publications, collaborative investigations, and international academic engagement. She has earned appointments as an associate professor across multiple academic programs and is an active member of numerous professional societies in dermatology and related fields, reflecting her recognized standing in the global medical community. Her professional certifications in medicine, dermatology, and hyperbaric and undersea medicine further attest to her clinical competence and commitment to continuous advancement. Dr. Liu’s combination of scholarly accomplishment, leadership experience, research productivity, and professional recognition positions her as an exemplary candidate for distinguished award nomination.

Profiles: ORCID

Featured Publications

1. Li, T. S., Wu, M. S., Sun, C. K., & Liu, Y. S. (2025). A novel banana method for surgical treatment of distal phalangeal glomus tumor. Asian Journal of Surgery, 48(11), 7228–7229.

2. Liu, Y. S., Lai, M. C., Hong, T. Y., & Liu, I. M. (2025). γ-Oryzanol: A nutrient-rich ingredient for promoting wound healing. Heliyon, 11(4), e42551.

3. Liu, Y.-S., Lai, M.-C., Tzeng, Y.-C., & Liu, I.-M. (2025). Polyphenolic hispolon derived from medicinal mushrooms of the Inonotus and Phellinus genera promotes wound healing in hyperglycemia-induced impairments. Nutrients, 17(2), 266.

4. Liu, Y.-S., Lai, M.-C., Hong, T.-Y., & Liu, I.-M. (2024). Exploring the wound healing potential of hispidin. Nutrients, 16(18), 3161.

5. Siregar, P., Liu, Y.-S., Casuga, F. P., Huang, C.-Y., Chen, K. H.-C., Huang, J.-C., Hung, C.-H., Lin, Y.-K., Hsiao, C.-D., & Lin, H.-Y. (2024). Optimization of laser-based method to conduct skin ablation in zebrafish and development of deep learning-based method for skin wound-size measurement. Inventions, 9(2), 25. (Co-first author)

Dr. Yi-Shan Liu’s work advances scientific understanding and clinical practice in dermatology, aesthetic medicine, and wound healing through integrative research and evidence-based innovation. Her contributions support improved patient outcomes, foster translational solutions for regenerative and anti-aging therapies, and strengthen global collaboration in emerging biomedical technologies.

Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Published on | Editorial Board by World Top Scientists

Dr. Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Javad Amini Mahabadi  | Kashan University of Medical Sciences | Iran

Dr. Javad Amini Mahabadi, a reproductive biologist and faculty member at Kashan University of Medical Sciences, is recognized for his expertise in reproductive biology, IVF, and stem-cell–based approaches to fertility science. He holds advanced degrees culminating in a Ph.D. in Reproductive Biology, with specialized training in assisted reproductive technologies and cellular therapeutics. His professional experience includes leading laboratory initiatives in gamete and embryo research, contributing to multidisciplinary reproductive health projects, mentoring emerging scientists, and supporting institutional development through academic and committee service. Dr. Amini Mahabadi’s research focuses on reproductive physiology, embryo development, and innovative stem-cell applications, reflected in a substantial body of peer-reviewed publications and a strong citation record demonstrating sustained scientific impact. His contributions extend to methodological advancements and collaborative work aimed at improving clinical and translational outcomes in reproductive medicine. He has received institutional and professional recognitions for research excellence, serves in editorial and peer-review roles for respected journals, and maintains active membership in scientific societies that promote reproductive health and biomedical innovation.

Profiles: Google Scholar

Featured Publications

1. Mohammadi, F., Nikzad, H., Taherian, A., Amini Mahabadi, J., & Salehi, M. (2013). Effects of herbal medicine on male infertility. Anatomical Sciences Journal, 10(4), 3–16.

2. Aghaei, S., Nikzad, H., Taghizadeh, M., Tameh, A. A., Taherian, A., & Moravveji, A. (2014). Protective effect of pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with cyclophosphamide. Andrologia, 46(8), 927–935.

3. Abazari, M. F., Soleimanifar, F., Aleagha, M. N., Torabinejad, S., Nasiri, N., … (2018). PCL/PVA nanofibrous scaffold improve insulin-producing cells generation from human induced pluripotent stem cells. Gene, 671, 50–57.

4. Abazari, M. F., Soleimanifar, F., Amini Faskhodi, M., Mansour, R. N., … (2020). Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. Journal of Cellular Physiology, 235(2), 1155–1164.

5. Tahmasebi, A. T., Enderami, S. E., Saburi, E., Islami, M., … (2019). MicroRNA incorporated electrospun nanofibers improve osteogenic differentiation of human induced pluripotent stem cells. Journal of Biomedical Materials Research, 108(2), 377–386.

Dr. Javad Amini Mahabadi’s work advances reproductive biology and stem-cell–based innovation, contributing to improved fertility outcomes and translational biomedical solutions. His research supports scientific progress, strengthens clinical practices, and fosters technologies that enhance public health and future therapeutic development.

Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Published on | Editorial Board by World Top Scientists

Dr. Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Research Associate | Iran University of Medical Sciences | Iran

Dr. Milad Shirvaliloo is an accomplished physician–researcher specializing in epigenetics with a focus on cancer and pulmonary medicine. Holding a Doctor of Medicine and a Master of Business Administration in Health Sciences, he combines clinical expertise with research innovation to advance precision medicine. As a Postgraduate Researcher at the Finetech in Medicine Research Center, he leads studies on nanoparticle-based therapeutic interventions and their effects on histone acetylation in cancer. Dr. Shirvaliloo has authored more than forty peer-reviewed publications and a book chapter, contributing extensively to understanding molecular and epigenetic mechanisms in disease pathogenesis. His scholarly output includes first-author and single-author papers in leading journals, where he explores the roles of histone modifications, long noncoding RNAs, and nanobiosensor technologies in diagnostics and therapeutics. He has demonstrated academic leadership as an Editorial Board Member for Epigenomics and Molecular and Cellular Biochemistry and has served as a peer reviewer for over sixty high-impact journals. Recognized for his scientific excellence and editorial contributions, he has received the Best Researcher Award for his outstanding achievements in biomedical science. His ongoing work reflects a strong commitment to translational research, interdisciplinary collaboration, and mentorship of emerging scientists. With a clear vision for integrating molecular biology, nanotechnology, and clinical application, Dr. Shirvaliloo exemplifies the future of innovative medical research and continues to make significant contributions to global health advancement.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & others. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.

2. Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & others. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.

3. Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.

4. Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & others. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.

5. Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & others. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.*

Dr. Milad Shirvaliloo’s pioneering research in epigenetics and nanomedicine bridges molecular science with clinical application, driving innovations in cancer and pulmonary disease diagnostics and therapies. His work advances precision medicine and fosters global scientific collaboration, contributing to more effective, personalized healthcare solutions.

Maria Morales-Suarez-Varela | Medicine and Pharmacy | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Prof. Dr. Maria Morales-Suarez-Varela | Medicine and Pharmacy | Best Researcher Award
Full professor | University of Valencia | Spain

Prof. Dr. Maria Morales-Suárez-Varela is a distinguished academic and researcher specializing in public health, preventive medicine, nutrition, and environmental epidemiology. Serving as a Full Professor at the Universitat de València, she has made outstanding contributions to advancing scientific understanding of the relationships between environmental exposures, nutrition, and population health. She holds a Doctorate and a Licentiate in Medicine and Surgery, with advanced expertise in preventive and public health sciences. As Principal Investigator of prominent research groups within the CIBER of Epidemiology and Public Health and the Universitat de València, she has led numerous national and international projects funded by competitive public and private agencies. Her scholarly impact is reflected in hundreds of high-quality publications indexed in leading databases, an extensive record of citations, and a strong h-index that underscores her scientific influence. She has supervised numerous doctoral theses and has presented extensively at global conferences. Her research integrates epidemiological evidence with policy-relevant health solutions, with special focus on maternal and child health, dietary patterns, environmental risks, and population well-being. Recognized for her leadership and excellence, she has received multiple distinctions for research merit and contributes actively to scientific networks, editorial boards, and peer-review committees. Prof. Morales-Suárez-Varela exemplifies academic rigor, innovation, and dedication to public health advancement, making her a highly deserving candidate for this award.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Morales-Suárez-Varela, M., et al. (2025). Effect of the Mediterranean diet on BMI and body composition: A preliminary pre-post intervention study in pediatric overweight patients. Nutrition.

2. Morales-Suárez-Varela, M., et al. (2025). Long-term prognostic implications of type 2 diabetes mellitus in colorectal cancer patients. Colorectal Disease.

3. Morales-Suárez-Varela, M., et al. (2025). Systematic review of prenatal exposure to PM2.5 and its chemical components and their effects on neurodevelopmental outcomes in neonates.

4. Morales-Suárez-Varela, M., et al. (2025). Helminth/Protozoan coinfections in chronic fascioliasis cases in human hyperendemic areas: High risk of multiparasitism linked to transmission aspects and immunological, environmental and social factors. Tropical Medicine and Infectious Disease.

5. Morales-Suárez-Varela, M., et al. (2025). Analysis of demographic and health characteristics and adherence to the Mediterranean diet in pregnant women: MEDAS questionnaire. Semergen.

Prof. Dr. Maria Morales-Suárez-Varela’s research advances global understanding of how environmental, nutritional, and lifestyle factors influence public health outcomes. Her work bridges science and policy, driving innovations that promote healthier populations, sustainable healthcare practices, and evidence-based prevention strategies worldwide.

Selcuk Comlekci | Bioengineering | Outstanding Scientist Award

Published on | Editorial Board by World Top Scientists

Prof. Selcuk Comlekci | Bioengineering | Outstanding Scientist Award

Professor | Suleyman Demirel University | Turkey

Assoc. Prof. Dr. Selçuk Çömlekçi is a distinguished faculty member at Süleyman Demirel University, Faculty of Engineering and Architecture, Department of Electronics and Communication Engineering in Isparta, Turkey. He holds a Ph.D. in Electrical and Electronics Engineering from Sakarya University, where he specialized in advanced electrical, electronic, and communication systems. With extensive academic and professional experience, he has served in various academic roles, including lecturer, assistant professor, and associate professor, contributing significantly to research, teaching, and innovation. His research expertise spans biomedical engineering, biophysics, electromagnetic and magnetic fields, microwave circuits, optoelectronic materials and devices, industrial and hazardous waste management, communication and control engineering, artificial intelligence, and fuzzy logic systems. Dr. Çömlekçi has participated in numerous national research projects focusing on areas such as wireless communication systems, nano-fiber production through electrospinning, and the development of electromagnetic shielding materials. His scientific work has contributed to advancements in biomedical signal processing, RF applications, and interdisciplinary engineering research. A respected academic and researcher, he has received recognition for his contributions to science and education and is actively involved in professional and scholarly communities through research collaborations, editorial engagements, and membership in scientific associations, exemplifying excellence and leadership in engineering and applied sciences.

Profiles: Google Scholar | Scopus

Featured Publications

1. Investigation of the efficiency of pulsed electromagnetic field treatment and stretching exercise in experimental skeletal muscle injury model. BMC Musculoskeletal Disorders, 2025.

2. Prophylactic effects of radiofrequency electromagnetic field on pulmonary ischemia-reperfusion via HIF-1α/eNOS pathway and BCL2/BAX signaling. Pulmonary Circulation, 2025.

3. Radiofrequency electromagnetic and pulsed magnetic fields protected the kidney against lipopolysaccharide-induced acute systemic inflammation, oxidative stress, and apoptosis by regulating the IL-6/HIF1α/eNOS and Bcl2/Bax/Cas-9 pathways. Medicina (Lithuania), 2025.

4. Effect of 10 kV/m electric field therapy in a pressure injury model in rats: An innovative preliminary report. Bioengineering, 2025.

5. Effect of short-term extremely low-frequency electromagnetic field on respiratory functions. Revista da Associação Médica Brasileira (1992), 2025.